Farther Finance Advisors, LLC

Position in CTKB — Cytek Biosciences, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in CTKB

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$642

-$127 QoQ

Shares Held

145

-17.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#144

of 154 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $24,008,567 across 89 Medical Devices names. CTKB ranks #69 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	73,946	$6,709,860
2	SYK	Stryker Corp	17,426	$5,486,401
3	MDT	Medtronic plc	65,993	$5,162,632
4	BSX	Boston Scientific Corp	28,699	$1,224,873
5	EW	Edwards Lifesciences Corp	12,482	$1,129,121
6	DXCM	Dexcom Inc	9,967	$671,277
7	STE	STERIS plc	2,980	$627,498
8	GEHC	GE HealthCare Technologies Inc.	8,545	$546,965

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$642	145	-17.6%	Shares	Sole	2026-07-17
2026-03-31	$769	176	+85.3%	Shares	Sole	2026-04-07
2025-12-31	$479	95	0.0%	Shares	Sole	2026-01-23
2025-09-30	$329	95	-98.0%	Shares	Sole	2025-10-14
2025-06-30	$16,561	4,871	+50.2%	Shares	Sole	2025-07-11
2025-03-31	$13,000	3,242	+288.3%	Shares	Sole	2025-04-14
2024-12-31	$5,419	835	-3.5%	Shares	Sole	2025-02-10
2024-09-30	$4,792	865	+2.0%	Shares	Sole	2024-10-29
2024-06-30	$4,731	848	+5.1%	Shares	Sole	2024-07-31
2024-03-31	$5,414	807	0.0%	Shares	Sole	2024-05-14
2023-12-31	$7,359	807	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.